Health
Controversial Peptides Back in the Spotlight: RFK Jr. Pressures FDA
April 16, 2026
0 views
The FDA is reconsidering restrictions on 12 unproven peptides after pressure from anti-vaccine activist Robert F. Kennedy Jr. The move raises concerns about safety and efficacy.
Controversial Peptides Back in the Spotlight: RFK Jr. Pressures FDA
In a surprising move, the Food and Drug Administration (FDA) has announced upcoming meetings to discuss lifting restrictions on 12 unproven peptides that the agency deemed risky in 2023. The meetings, scheduled for July and February 2027, come at the behest of anti-vaccine activist Robert F. Kennedy Jr., who has described himself as a
Source: Ars Technica
Health
compounding pharmacies
Peptides
fda
robert f kennedy jr
